Actualización del manejo clínico del cáncer mamario asociado al embarazo. Revisión de la Literatura
PDF

Cómo citar

Álvarez Tapias, C., Cifuentes Borrero, R., Mosquera Luna, R., Moreno Cortes, E., Idrobo Quintero, H., Lazzaro, rancesco, & Álvarez, R. (2017). Actualización del manejo clínico del cáncer mamario asociado al embarazo. Revisión de la Literatura. Revista Colombiana Salud Libre, 12(2), 50-59. Recuperado a partir de https://revistas.unilibre.edu.co/index.php/rcslibre/article/view/1735

Resumen

El embarazo asociado a cáncer de mama (CMAE) es definido como el cáncer de mama que se diagnostica durante el embarazo o dentro de primer año posparto. La incidencia de cáncer de mama durante el embarazo es aproximadamente 1 de cada 3.000 y el cáncer de mama es la segunda neoplasia maligna más común en el embarazo, el cáncer de mama durante el embarazo es una circunstancia compleja por todas las implicaciones que se pueden producir sobre el feto en el tratamiento oncológico. Debe tenerse suficiente información para no retrasar el diagnóstico y tratar de manera adecuada a las pacientes, este debe estar soportado por grupo multidisciplinario. El objetivo de la atención a las mujeres con CMAE es el control local de la enfermedad y la prevención de la metástasis. Hay una escasez de estudios prospectivos en relación con el diagnóstico y el tratamiento del cáncer de mama durante el embarazo por lo tanto generar conocimiento acerca de las características clínico – patológicas, y tanto el resultado oncológico como perinatal de la paciente es muy importante. Se realizo una revision de los estudios con mayor evidencia respecto a este tema con el objetivo de generar mayor conocimiento en cuanto a esta patología así optimizar el manejo y reducir el retraso en el diagnóstico de las mujeres con CMAE.

PDF

Citas

1. Pilewskie M, Gorodinsky P, Fought A, Hansen N, Bethke K, Jeruss J, et al. Association between recen- cy of last pregnancy and biologic subtype of breast cancer. Ann Surg Oncol. 2012 Apr;19(4):1167–73.

2. Loibl S, Schmidt A, Gentilini O, Kaufman B, Kuhl C, Denkert C, et al. Breast Cancer Diagnosed During Pregnancy. JAMA Oncol. 2015;1(8):1145.

3. Carkaci S, Sherman CT, Ozkan E, Adrada BE, Wei W, Rohren EM, et al. 18F-FDG PET/CT predicts survival in patients with inflammatory breast cancer undergoing neoadjuvant chemotherapy. Eur J Nucl Med Mol Imaging. 2013;40(12):1809–16.

4. Loibl S, Han SN, von Minckwitz G, Bontenbal M, Ring A, Giermek J, et al. Treatment of breast cancer during pregnancy: An observational study. Lancet Oncol. 2012;13(9):887–96.

5. Andersson TM-L, Johansson AL V, Hsieh C-C, Cnattingius S, Lambe M. Increasing incidence of pregnancy-associated breast cancer in Sweden. Obstet Gynecol. 2009;114(3):568–72.

6. Meier-Abt F, Bentires-Alj M. How pregnancy at early age protects against breast cancer. Trends Mol Med. 2014;20(3):143–53.

7. Albrektsen G, Heuch I, Hansen S, Kvåle G. Breast cancer risk by age at birth, time since birth and time intervals between births: exploring interaction effects. Br J Cancer. 2005;92(1):167–75.

8. Emerson JD, Colditz G a. Use of Statistical Analysis in The New England Journal of Medicine. N Engl J Med. 1983;309(12):709–13.

9. Wohlfahrt J, Andersen PK, Mouridsen HT, Melbye M. Risk of late-stage breast cancer after a childbirth. Am J Epidemiol. 2001;153(11):1079–84.

10. Ishida T1, Yokoe T, Kasumi F, Sakamoto G, Makita M, Tominaga T, Simozuma K, Enomoto K, Fujiwara K, Nanasawa T et al. Clinicopathologic characteristics and prognosis of breast cancer pa- tients associated with pregnancy and lactation: analysis of case-control study in Japan. Jpn J Cancer Res. 1992;83(83(11)):1143–9.

11. Johansson AL V, Andersson TML, Hsieh CC, Jirström K, Dickman P, Cnattingius S, et al. Sta- ge at diagnosis and mortality in women with pregnancy-associated breast cancer (PABC). Breast Cancer Res Treat. 2013;139(1):183–92.

12. Antoniou AC, Shenton A, Maher ER, Watson E, Woodward E, Lalloo F, et al. Parity and breast can- cer risk among BRCA1 and BRCA2 mutation carriers. Breast Cancer Res. 2006;8(6):R72.

13. Ali SA, Gupta S, Sehgal R, Vogel V. Survival outco- mes in pregnancy associated breast cancer: A retros- pective case control study. Breast J. 2012;18(2):139– 44.

14. Burgos Portillo I, Mainero Ratchelou FE, Roxana Burgos Portillo D, Jaimes Cadena M. Patología de la mama durante el embarazo y lactancia patología de la mama durante el embarazo y lactancia. Rev Med La Paz. 2012;18(1):57–66.

15. Zemlickis D, Lishner M, Degendorfer P, Panzarella T, Sutcliffe SB, Koren G. Maternal and fetal outcome after invasive cervical cancer i n pregnancy. J Clin Oncol. Mosby; 1991;9(11):1956–61.

16. Amant F, Deckers S, Van Calsteren K, Loibl S, Halaska M, Brepoels L, et al. Breast cancer in preg- nancy: Recommendations of an international consensus meeting. Eur J Cancer. 2010;46(18):3158– 68.

17. Reena Vashi1, 2, Regina Hooley1, Reni Butler1, Jaime Geisel1 and LP. Breast Imaging of the Preg- nant and Lactating Patient: Physiologic Chan- ges and Common Benign Entities. Am J Roentgenol Diagnostic Imaging Relat Sci. 2013;200(10.2214/ AJR.12.9845):329–36.

18. Nicklas A, Baker M. Imaging strategies in the preg- nant cancer patient. Semin Oncol. 27(6):623–32.

19. Yang WT, Dryden MJ, Gwyn K, Whitman GJ, The- riault R. Imaging of Breast Cancer Diagnosed and Treated with Chemotherapy during Pregnancy 1. Radiology. 2006;239(1):52–60.

20. Mazonakis M, Varveris H, Damilakis J, Theoha- ropoulos N, Gourtsoyiannis N. Radiation dose to conceptus resulting from t a n g e n t i a l breast irradiation. Int J Radiat Oncol Biol Phys. 2003;55(2):386–91.

21. Stovall M, American Institute of Physics., American Association of Physicists in Medicine. Fetal dose from radiotherapy with photon beams. AAPM Rep. 1995;(No 50):p. 63–82.

22. Amant F, Loibl S, Neven P, Van Calsteren K. Breast cancer in pregnancy. Lancet. 2012;379(9815):570– 9.

23. Amant F, Loibl S, Neven P, Van Calsteren K. Breast cancer in pregnancy. Lancet. 2012;379(9815):570– 9.1

24. Cardonick E. Pregnancy-associated breast cancer: Optimal treatment options. Int J Womens Health. 2014;6:935–43.

25. Dominici LS, Kuerer HM BG et al. Wound compli- cations from surgery in pregnancy-associated breast cancer (PABC)1. Breast Dis. 2010;31(1–5).

26. Hahn KME, Johnson PH, Gordon N, Kuerer H, Middleton L, Ramirez M, et al. Treatment of pregnant breast cancer patients and outcomes of children exposed to chemotherapy in utero. Can- cer. 2006;107(6):1219–26.

27. Abdel-Hady el-S, Hemida RA, Gamal A, et al. Cancer during pregnancy: perinatal outcome after in utero exposure to chemotherapy. Arch Gynecol Obstet. 2012;286(2):283-286.

28. Howdeshell KL, Shelby MD, Walker VR, Thayer K a. Developmental Effects and Pregnancy Outcomes Associated with Cancer Chemotherapy use during Pregnancy. NTP Monogr. 2013;(May).

29. Litton JK, Theriault RL. Breast cancer and pregnan- cy: current concepts in diagnosis and treatment. Oncologist. 2010;15(12):1238–47.

30. Vinatier E, Merlot B, Poncelet E, Collinet P, Vina- tier D. Breast cancer during pregnancy. Eur J Obstet Gynecol Reprod Biol. 2009;147(1):9–14.

31. Behrman RH, Homer MJ, Yang WT et al. Mammo- graphy and fetal dose. Radiology. 2007;243:605(605- 6.).

32. Ann ICRP. International Commission on Radiological Protection (ICRP). Pregnancy and medical radiation: ICRP Publication. Ann ICRP. 2000;84. ;30(1-43.).

33. Reefy S Al, Kameshki R. Intracystic papillary breast cancer: a clinical update. Ecancer. 2013;7:1–5.

34. Azim HA Jr, Botteri E, Renne G et al. The biological features and prognosis of breast cancer diagnosed during pregnancy: a case-control study. Acta Oncol. 2012;51(653-61).

35. Martin DD. Review of radiation therapy in the pregnant cancer patient. Clin Obstet Gynecol. 2011;54(4):591–601.

36. Van Giessen PH Der. Measurement of the peri- pheral dose for the tangential breast treatment technique with Co-60 gamma radiation and high energy X-rays. Radiother Oncol. 1997;42(3):257–64.

37. Pentheroudakis G, Orecchia R, Hoekstra HJ, Pa- vlidis N. Cancer, fertility and pregnancy: ESMO Clinical Practice Guidelines for diagnosis, treat- ment and follow-up. Ann Oncol. 2010;21(SUPPL. 5):266–73.

38. Kal HB, Struikmans H. Radiotherapy during preg- nancy: Fact and fiction. Lancet Oncol. 2005;6(5):328– 33.

39. Guidroz J a., Scott-Conner CEH, Weigel RJ. Manage- ment of pregnant women with breast cancer. J Surg Oncol. 2011;103(4):337–40.

40. Sur RK, Clinkard J, Jones WG, Taylor RE, Close HJ, Chaturvedi A, et al. Breast Cancer and Pregnancy: The Ultimate Challenge. Clin Oncol. 1989;1:11–8.

41. Hoover HC Jr. Breast cancer during pregnancy and lactation. Surg Clin North Am. 1990;70(1151–1163).

42. Nugent, P. and TX, O. Breast cancer and pregnancy. Archives of Surgery. 1985;120(11), pp. 1221–1224.

43. Zemlickis D, Lishner M, Degendorfer M, Panzarella T, Sutcliffe SB, G K. Maternal and fetal outcome after invasive cervical cancer in pregnancy. J Clin Oncol. 1991;9(11):1956–61.

44. Kroman N, Jensen M-B, Wohlfahrt J, Ejlertsen B. Pregnancy after treatment of breast cancer--a popu- lation-based study on behalf of Danish Breast Cancer Cooperative Group. Acta Oncol. 2008;47(4):545–9.

45. Clark RM, Reid J. Carcinoma of the breast in preg- nancy and lactation. Int J Radiat Oncol Biol Phys. 1978 Jul 1;4(7):693–8.

46. Lethaby, A. E., O’Neill, M. A., Mason, B. H., Hol- daway, I. M. and Harvey, V. J. (1996), Overall survival from breast cancer in women pregnant or lactating at or after diagnosis. Int. J. Cancer, 67: 751–755

47. Mueller BA, Simon MS, Deapen D, Kamineni A, Malone KE, Daling JR. Childbearing and survival after breast carcinoma in young women. Cancer. 2003;98(6):1131–40.

48. Beadle BM, Woodward Wa, Middleton LP, Tereffe W, Strom E a, Litton JK, et al. The impact of preg- nancy on breast cancer outcomes in women
49. Dietz, J.R., Partridge, A.H., Gemignani, M.L. et al. Breast Cancer Management Updates: Young and Older, Pregnant, or Male. Ann Surg Oncol (2015) 22: 3219.

50. Theodoros N. Sergentanis, Andreas-Antonios Dia- mantaras, Christina Perlepe, Prodromos Kanavidis, Alkistis Skalkidou, Eleni Th. Petridou; IVF and breast cancer: a systematic review and meta-analy- sis, Human Reproduction Update, Volume 20, Issue 1, 1 January 2014, Pages 106–123

51. Monteiro DLM, Trajano AJB, Menezes DCS, Sil- veira NLM, Magalhães AC, Miranda FRD de, et al. Câncer de mama na gravidez e quimioterapia: revisão sistemática. Rev Assoc Med Bras [Internet]. 2013;59(2):174–80.

52. Monteiro DLM, Trajano AJB, Menezes DCS, Sil- veira NLM, Magalhães AC, Miranda FRD de, et al. Câncer de mama na gravidez e quimioterapia: revisão sistemática. Rev Assoc Med Bras [Internet]. 2013;59(2):174–80.

Descargas

La descarga de datos todavía no está disponible.